REQUEST A DEMO
Total
USD $0.00
Search more companies

Neurosupport S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Commercial and Industrial Machinery and Equipment Rental and Leasing | All Other Professional, Scientific, and Technical Services
Full name: Neurosupport S.A.S. Profile Updated: May 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Neurosupport S.A.S. is a company based in Colombia, with its head office in Bucaramanga. It operates in the Diagnostic Imaging Centers sector. Neurosupport S.A.S. was incorporated on March 02, 2022. Neurosupport S.A.S. currently employs 1 (2026) people. In its most recent financial highlights, the company reported a net sales revenue increase of 29.14% in 2025. During that time, Neurosupport S.A.S.’s total assets grew by 1.01%. The net profit margin of Neurosupport S.A.S. increased by 8.18% in 2025.

Headquarters
Carrera 46 # 56 - 108
Bucaramanga; Santander;

Contact Details: Purchase the Neurosupport S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Neurosupport S.A.S. report to view the information.
Financial Auditors:
Purchase the Neurosupport S.A.S. report to view the information.
Incorporation Date:
March 02, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Neurosupport S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
29.14%
Total Operating Revenue
29.14%
Net Profit/Loss for the Period
237.05%
Total Assets
1.01%
Total Equity
131.18%
Net Profit Margin
8.18%
Return on Equity (ROE)
17.82%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?